Israel’s GiraSol Renewable Energy builds and maintains solar energy systems using the best global technology to check for performance issues. GiraSol’s clients include Israel’s Energix and France’s EDF, which operates large solar farms in Israel. https://nocamels.com/2024/07/startup-transforming-israels-solar-ecosystem-into-a-global-affair/

The UK chemist chain Boots is now selling Salistick, the world’s first saliva-based pregnancy test, from Israel’s Salignostics (see here previously). https://www.abingdonhealth.com/news/boots-launches-the-salivia-pregnancy-self-test/ https://www.boots.com/boots-saliva-pregnancy-test-2-pack-10340838

Israel’s Medasense (see here previously) is partnering with Nihon Kohden for the exclusive distribution of its revolutionary PMD-200 real-time non-invasive pain monitoring device in Japan. https://medasense.com/medasense-announces-a-strategic-agreement-with-global-medical-company-nihon-kohden-corporation/

Nine Israeli startups have secured a total of $142 million in funding from the EU Horizon (EIC Accelerator) program. They include MediWound (EscharEx), JaxBio, Nurami, LightSolver, Quantum Transistors, RAAAM Memory, Reophotonics (ioTech), SpacePharma, and Impact Biotech. https://www.timesofisrael.com/nine-israeli-startups-secure-142-million-in-funding-from-eu-horizon-program/ https://www.mediwound.com/products/escharex/ https://jaxbio.com/ https://quantumtransistors.com/ … Continue reading →

Israel’s Upword (see here previously) attracted 30,000 users for its Beta version, with 1,000 paying for its advanced GenAI capabilities. Upword is designed to mimic the traditional research methods required by professionals, researchers and academics and has now launched its … Continue reading →

Holding our breath for Google’s expected $23 billion takeover of Israel’s Wiz. Meanwhile, Edwards Lifesciences has acquired Israel’s Innovalve for $300 million. US-based Tricentis has acquired Israel’s SeaLights for around $150 million.

CTERA raised $80 million; CytoReason raised $80 million; OCON Therapeutics raised $10 million; HAGAR raised $5 million (total $25 million); Acculine raised $4.2 million; Upword raised $3 million;